Worldline Shares Jump on Report Credit Agricole Is Weighing Stake
By Mauro Orru
Worldline shares climbed in Friday afternoon trading after Bloomberg reported that Credit Agricole is weighing building a stake in the French payments company, taking advantage of Worldline's share price that lost more than half of its value this year.
At 1400 GMT, Worldline shares traded 5% higher at EUR14.94.
The French bank has discussed a potential stake acquisition after Worldline's share price plunged in recent weeks, Bloomberg reported citing people familiar with the matter. Credit Agricole and Worldline declined to comment.
The report comes just over a month after Worldline shares lost more than half of their value following third-quarter revenue below analysts' expectations and a cut to guidance for the year due to what the group called challenging macroeconomic conditions. Worldline shares are down almost 60% since the year began.
Consumers have diverted more of their spending to so-called nondiscretionary expenses that are deemed essential such as housing and food, rather than discretionary expenses like entertainment or luxury goods, a development that harmed its profitability, Worldline said.
European consumers are grappling with inflation and high interest rates that are testing their spending habits, forcing many to prioritize essentials such as food over the occasional indulgence.
Write to Mauro Orru at mauro.orru@wsj.com
(END) Dow Jones Newswires
December 01, 2023 09:31 ET (14:31 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks